Hostility differentiates the brain metabolic effects of nicotine. 2004

James H Fallon, and David B Keator, and James Mbogori, and Jessica Turner, and Steven G Potkin
Department of Anatomy and Neurobiology, University of California, Irvine, BIRN-RP, 5251 California, Suite 240, Irvine, CA 92697-3960, USA.

The brain mechanisms underlying the cause of nicotine dependence are unknown, however, hostility traits are associated with increased susceptibility to nicotine dependence. We used FDG PET to measure brain metabolic response to nicotine administered by patch while the subject performed the Bushman aggression task in 86 high- and low-hostility subjects. Low-hostility trait subjects demonstrated no significant change in brain metabolic response to nicotine. In marked contrast, high-hostility non-smokers subjects demonstrated dramatic metabolic changes to low dose (3.5 mg patch) as did high-hostility smokers to high dose nicotine (21 mg patch) throughout the brain bilaterally (p<0.025). Correlational analyses demonstrated greater metabolic changes in response to nicotine in subjects with greatest hostility trait measures. The observed differences were not a consequence of plasma nicotine or cotinine levels. These metabolic changes were not observed when subjects performed a sustained attentional task (continuous performance task; CPT). Behaviorally, high-hostility subjects had higher ratings of anger, impatience, irritability and nervousness, and lower ratings of happiness, relaxation and curiosity than low-hostility subjects. Smokers had significantly greater scores on impatience and restlessness than non-smokers. This PET study demonstrates a conspicuous lack of the brain metabolic response to nicotine in low-hostility non-smokers in contrast to a dramatic brain response to nicotine in high hostility subjects. This biological difference in brain metabolic response to nicotine between high and low hostility trait subjects may explain differences in susceptibility to nicotine dependence.

UI MeSH Term Description Entries
D008297 Male Males
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006791 Hostility Tendency to feel anger toward and to seek to inflict harm upon a person or group. Hostilities
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

James H Fallon, and David B Keator, and James Mbogori, and Jessica Turner, and Steven G Potkin
February 2001, Neurochemical research,
James H Fallon, and David B Keator, and James Mbogori, and Jessica Turner, and Steven G Potkin
November 1990, Sports medicine (Auckland, N.Z.),
James H Fallon, and David B Keator, and James Mbogori, and Jessica Turner, and Steven G Potkin
November 1989, Acta physiologica Scandinavica,
James H Fallon, and David B Keator, and James Mbogori, and Jessica Turner, and Steven G Potkin
September 1995, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie,
James H Fallon, and David B Keator, and James Mbogori, and Jessica Turner, and Steven G Potkin
January 1982, Pharmacology & therapeutics,
James H Fallon, and David B Keator, and James Mbogori, and Jessica Turner, and Steven G Potkin
July 2020, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco,
James H Fallon, and David B Keator, and James Mbogori, and Jessica Turner, and Steven G Potkin
April 1985, European journal of pharmacology,
James H Fallon, and David B Keator, and James Mbogori, and Jessica Turner, and Steven G Potkin
May 2009, Pharmacology & therapeutics,
James H Fallon, and David B Keator, and James Mbogori, and Jessica Turner, and Steven G Potkin
December 2005, The American journal of cardiology,
James H Fallon, and David B Keator, and James Mbogori, and Jessica Turner, and Steven G Potkin
January 2013, Frontiers in pharmacology,
Copied contents to your clipboard!